These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 28667062)

  • 61. Optogenetic approaches to study the mammalian brain.
    Deubner J; Coulon P; Diester I
    Curr Opin Struct Biol; 2019 Aug; 57():157-163. PubMed ID: 31082625
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Lamprey Parapinopsin ("UVLamP"): a Bistable UV-Sensitive Optogenetic Switch for Ultrafast Control of GPCR Pathways.
    Eickelbeck D; Rudack T; Tennigkeit SA; Surdin T; Karapinar R; Schwitalla JC; Mücher B; Shulman M; Scherlo M; Althoff P; Mark MD; Gerwert K; Herlitze S
    Chembiochem; 2020 Mar; 21(5):612-617. PubMed ID: 31468691
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Optogenetic manipulation of neural activity in C. elegans: from synapse to circuits and behaviour.
    Husson SJ; Gottschalk A; Leifer AM
    Biol Cell; 2013 Jun; 105(6):235-50. PubMed ID: 23458457
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Shining light on translational research in deep brain stimulation].
    Lüscher C; Davoine E; Bellone C
    Rev Med Suisse; 2015 Apr; 11(472):987-8, 990-1. PubMed ID: 26062226
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Optogenetic investigation of neuropsychiatric diseases.
    Huang F; Tang B; Jiang H
    Int J Neurosci; 2013 Jan; 123(1):7-16. PubMed ID: 23002710
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The clinical potential of optogenetic interrogation of pathogenesis.
    Gao TT; Oh TJ; Mehta K; Huang YA; Camp T; Fan H; Han JW; Barnes CM; Zhang K
    Clin Transl Med; 2023 May; 13(5):e1243. PubMed ID: 37132114
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Advantages and limitations of the use of optogenetic approach in studying fast-scale spike encoding.
    Malyshev A; Goz R; LoTurco JJ; Volgushev M
    PLoS One; 2015; 10(4):e0122286. PubMed ID: 25850004
    [TBL] [Abstract][Full Text] [Related]  

  • 68. The behavioral treatment of epilepsy generation and inhibition of seizures.
    Fenwick P
    Neurol Clin; 1994 Feb; 12(1):175-202. PubMed ID: 8183209
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Optogenetic versus Electrical Stimulation of Human Cardiomyocytes: Modeling Insights.
    Williams JC; Entcheva E
    Biophys J; 2015 Apr; 108(8):1934-45. PubMed ID: 25902433
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Application of Optogenetics in Gene Therapy.
    Kushibiki T; Ishihara M
    Curr Gene Ther; 2018; 18(1):40-44. PubMed ID: 29512463
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Recent developments in optical neuromodulation technologies.
    Kos A; Loohuis NF; Glennon JC; Celikel T; Martens GJ; Tiesinga PH; Aschrafi A
    Mol Neurobiol; 2013 Feb; 47(1):172-85. PubMed ID: 23065387
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [An overview of epilepsy: its history, classification, pathophysiology and management].
    Hirose G
    Brain Nerve; 2013 May; 65(5):509-20. PubMed ID: 23667116
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Evaluating the Potential of Light Exposure on Reducing the Frequency of Epileptic Seizures.
    AlDajani BA; Uzair M; Qaiser H; Mir A; Mohammad Saleh N; Al Baradie R; Tahseen S; Bashir S
    CNS Neurol Disord Drug Targets; 2024; 23(4):463-467. PubMed ID: 37026496
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Optogenetic regulation of transcription.
    Polesskaya O; Baranova A; Bui S; Kondratev N; Kananykhina E; Nazarenko O; Shapiro T; Nardia FB; Kornienko V; Chandhoke V; Stadler I; Lanzafame R; Myakishev-Rempel M
    BMC Neurosci; 2018 Apr; 19(Suppl 1):12. PubMed ID: 29745855
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Seizing Control: From Current Treatments to Optogenetic Interventions in Epilepsy.
    Bui AD; Alexander A; Soltesz I
    Neuroscientist; 2017 Feb; 23(1):68-81. PubMed ID: 26700888
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Optogenetic control of thalamus as a tool for interrupting penicillin induced seizures.
    Han Y; Ma F; Li H; Wang Y; Xu K
    Annu Int Conf IEEE Eng Med Biol Soc; 2015; 2015():6606-9. PubMed ID: 26737807
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Targeting Neural Circuits.
    Rajasethupathy P; Ferenczi E; Deisseroth K
    Cell; 2016 Apr; 165(3):524-34. PubMed ID: 27104976
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Optical Techniques in Optogenetics.
    Mohanty SK; Lakshminarayananan V
    J Mod Opt; 2015; 62(12):949-970. PubMed ID: 26412943
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Multimodal Functional Analysis Platform: 4. Optogenetics-Induced Oscillatory Activation to Explore Neural Circuits.
    Mushiake H; Ohshiro T; Osawa SI; Hosaka R; Katayama N; Tanaka T; Yawo H; Osanai M
    Adv Exp Med Biol; 2021; 1293():501-509. PubMed ID: 33398837
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Nanostructure Endows Neurotherapeutic Potential in Optogenetics: Current Development and Future Prospects.
    Sardoiwala MN; Srivastava AK; Karmakar S; Roy Choudhury S
    ACS Chem Neurosci; 2019 Aug; 10(8):3375-3385. PubMed ID: 31244053
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.